Your browser doesn't support javascript.
Reply to Chan, et al.
Zhao, Liyang; Li, Yusi; Yi, Wenjuan; Yan, Kuo; Yang, Chao; Radhakrishnan, Sridhar; Li, Rui; Tan, Ruirong; Fan, Gang; Dai, Mengyuan; Liu, Miao; Shao, Ning-Yi.
  • Zhao L; Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Taipa, Macau, China.
  • Li Y; Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Taipa, Macau, China.
  • Yi W; Department of Dermatology, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Yan K; Institute of Cell and Neurobiology, Charité Medical University, Berlin, Germany.
  • Yang C; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Radhakrishnan S; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Li R; Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Tan R; Translational Chinese Medicine Key Laboratory of Sichuan Province, Sichuan Institute for Translational Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Chengdu, China.
  • Fan G; Department of Urology, Huazhong University of Science and Technology Union Shenzhen Hospital, The 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China.
  • Dai M; Department of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Liu M; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Shao NY; Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Taipa, Macau, China.
J Med Virol ; 2022 Nov 04.
Article in English | MEDLINE | ID: covidwho-2246770
ABSTRACT
We appreciate the comments from Chan et al. for our study, and have carefully responded to the comments of Chan et al. and are very grateful for their praise of our research. We agree that smoking might be a risk factor of the severity of COVID-19 as mentioned by Chan et al., but in our study, smoking was not so robust compared with our conclusion. Also, we strongly agreed with the opinion of Chan, et al. that COVID-19 patients with diabetes or other chronic diseases might worsen the situation of the disease. But these factors were out of the scope of our study and we had published other research on this topic related to diabetes. Because of the limited sample size and original medical records, our study could not cover many factors suggested as Chan, et al. But we wish our study will be a useful and meaningful pilot study for the future studies. This article is protected by copyright. All rights reserved.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Year: 2022 Document Type: Article Affiliation country: Jmv.28283

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Year: 2022 Document Type: Article Affiliation country: Jmv.28283